Markus Radsak Selected Research

Hypertrophy

5/2009

Impaired mast cell-driven immune responses in mice lacking the transcription factor NFATc2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Markus Radsak Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 09/2010
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 01/2018
3	Autoimmune Diseases (Autoimmune Disease) 12/2021 - 08/2011
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2022 - 10/2017
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2021 - 05/2015
2	Inflammation (Inflammations) 10/2017 - 12/2014
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 05/2015 - 08/2011
1	Mast-Cell Leukemia (Leukemia, Mast Cell) 03/2024
1	Systemic Mastocytosis 03/2024
1	Hematologic Neoplasms (Hematological Malignancy) 03/2024
1	Anemia 11/2022
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Aspergillosis 01/2022
1	Carcinogenesis 01/2022
1	Leukemia 01/2022
1	Pregnancy Complications 12/2021
1	Thrombosis (Thrombus) 12/2021
1	Febrile Neutropenia 01/2019
1	Sepsis (Septicemia) 01/2019
1	Nausea 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Fever (Fevers) 01/2019
1	Septic Shock (Toxic Shock Syndrome) 01/2019
1	Lung Neoplasms (Lung Cancer) 07/2018
1	Cryopyrin-Associated Periodic Syndromes 10/2017
1	Bruton type agammaglobulinemia 10/2017
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2014
1	Skin Diseases (Skin Disease) 12/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2014
1	Hypertension (High Blood Pressure) 12/2014
1	Colitis 10/2012
1	Ulcerative Colitis 10/2012
1	Crohn Disease (Crohn's Disease) 10/2012
1	Hypertrophy 05/2009

Drug/Important Bio-Agent (IBA)

3	Antiphospholipid AntibodiesIBA 12/2021 - 08/2011
2	luspaterceptIBA 11/2022 - 10/2017
2	CytokinesIBA 12/2014 - 05/2009
1	Erythropoietin FDA Link 11/2022
1	hydrogen sulfite (bisulfite)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	IntegrinsIBA 01/2022
1	Endothelial Protein C ReceptorIBA 12/2021
1	bis(monoacylglyceryl)phosphateIBA 12/2021
1	Surface Antigens (Surface Antigen)IBA 12/2021
1	quizartinibIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 11/2018
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 07/2018
1	Core Binding Factors (Core-Binding Factor)IBA 01/2018
1	Dasatinib (BMS 354825)FDA Link 01/2018
1	ibrutinibIBA 10/2017
1	InflammasomesIBA 10/2017
1	Immunoglobulin G (IgG)IBA 05/2015
1	NADPH Oxidases (NAD(P)H oxidase)IBA 05/2015
1	Peroxidase (Myeloperoxidase)IBA 12/2014
1	InterleukinsIBA 12/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2014
1	Interleukin-17 (Interleukin 17)IBA 12/2014
1	Messenger RNA (mRNA)IBA 10/2012
1	AutoantigensIBA 09/2010

Therapy/Procedure

2	Immunotherapy 01/2022 - 09/2010
1	Cell Transplantation 03/2024
1	Drug Therapy (Chemotherapy) 01/2019
1	Consolidation Chemotherapy 01/2018
1	Therapeutics 10/2017
1	Erythrocyte Transfusion 10/2017